One Stop Systems, Inc. (OSS), a leader in rugged enterprise-class computing for AI, has announced a new $2 million production contract from an innovative medical imaging OEM focused on non-invasive breast cancer screening. This contract is part of a larger program expected to exceed $25 million over the next five years as OSS expands into commercial edge AI markets. Under the agreement, OSS will supply 65 next-generation liquid-cooled 3U-SDS units, which are integral to the OEM's breast scanning devices. Revenue from this contract is anticipated within the next six to twelve months, marking the transition from pilot to volume production. This engagement highlights OSS's ability to meet demanding requirements in high-growth verticals, leveraging its expertise in delivering high-density compute solutions at the rugged edge.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.